Vallon Pharmaceuticals Inc. (NASDAQ:VLON) went up by 13.16% from its latest closing price compared to the recent 1-year high of $9.90. The company’s stock price has collected 20.10% of gains in the last five trading sessions. Press Release reported on 05/13/21 that Vallon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
Is It Worth Investing in Vallon Pharmaceuticals Inc. (NASDAQ :VLON) Right Now?
Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Vallon Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $12.00. VLON currently public float of 3.10M and currently shorts hold a 0.96% ratio of that float. Today, the average trading volume of VLON was 50.65K shares.
VLON’s Market Performance
VLON stocks went up by 20.10% for the week, with a monthly jump of 24.05% and a quarterly performance of -16.95%. The volatility ratio for the week stands at 13.34% while the volatility levels for the past 30 days are set at 9.18% for Vallon Pharmaceuticals Inc.. The simple moving average for the period of the last 20 days is 22.77% for VLON stocks with a simple moving average of -0.32% for the last 200 days.
VLON Trading at 14.87% from the 50-Day Moving Average
After a stumble in the market that brought VLON to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -50.51% of loss for the given period.
Volatility was left at 9.18%, however, over the last 30 days, the volatility rate increased by 13.34%, as shares surge +30.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.89% upper at present.
During the last 5 trading sessions, VLON rose by +20.10%, in comparison to the 20-day moving average, which settled at $4.05. In addition, Vallon Pharmaceuticals Inc. saw -34.84% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at VLON starting from Kelly Leanne M., who purchase 1,508 shares at the price of $4.08 back on Jun 04. After this action, Kelly Leanne M. now owns 6,250 shares of Vallon Pharmaceuticals Inc., valued at $6,153 using the latest closing price.
Kelly Leanne M., the Chief Financial Officer of Vallon Pharmaceuticals Inc., purchase 1,085 shares at $4.05 during a trade that took place back on Jun 03, which means that Kelly Leanne M. is holding 4,742 shares at $4,394 based on the most recent closing price.
Stock Fundamentals for VLON
Current profitability levels for the company are sitting at:
- -4788.00 for the present operating margin
The net margin for Vallon Pharmaceuticals Inc. stands at -4822.00. The total capital return value is set at -393.13, while invested capital returns managed to touch -438.73. Equity return is now at value -218.80, with -128.60 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.30.